Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19.

Document Type

Article

Publication Date

5-23-2022

Publication Title

Cureus

Abstract

Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.

Volume

14

Issue

5

First Page

e25264

DOI

10.7759/cureus.25264

ISSN

2168-8184

PubMed ID

35755512

Link to Full Text

Share

COinS